Literature DB >> 25975837

ALK-negative anaplastic large cell lymphoma is sensitive to bortezomib through Noxa upregulation and release of Bax from Bcl-2.

Saskia A G M Cillessen1, Nathalie J Hijmering2, Laura M Moesbergen2, Wim Vos2, Sue Ellen Verbrugge3, Gerrit Jansen3, Otto J Visser4, Joost J Oudejans5, Chris J L M Meijer2.   

Abstract

Entities:  

Keywords:  Bcl-2; Noxa; anaplastic large cell lymphoma; apoptosis; bortezomib; chemotherapy-resistance

Mesh：

Substances：

Year:  2015        PMID： 25975837      PMCID： PMC4800697          DOI： 10.3324/haematol.2014.118828

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Consequences of heat shock protein 72 (Hsp72) expression and activity on stress-induced apoptosis in CD30+ NPM-ALK+ anaplastic large-cell lymphomas.

Authors:  P Bonvini; E Zorzi; L Mussolin; M Pillon; C Romualdi; M Peron; E S G d'Amore; L Lamant; A Rosolen
Journal:  Leukemia       Date:  2012-01-06       Impact factor: 11.528

2.  Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis.

Authors:  Alessio Nencioni; Fei Hua; Christopher P Dillon; Rayka Yokoo; Christoph Scheiermann; Mike H Cardone; Eleonora Barbieri; Ilaria Rocco; Anna Garuti; Sebastian Wesselborg; Claus Belka; Peter Brossart; Franco Patrone; Alberto Ballestrero
Journal:  Blood       Date:  2004-12-21       Impact factor: 22.113

3.  The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.

Authors:  T Hideshima; P Richardson; D Chauhan; V J Palombella; P J Elliott; J Adams; K C Anderson
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

4.  Noxa/Bcl-2 protein interactions contribute to bortezomib resistance in human lymphoid cells.

Authors:  Alyson J Smith; Haiming Dai; Cristina Correia; Rie Takahashi; Sun-Hee Lee; Ingo Schmitz; Scott H Kaufmann
Journal:  J Biol Chem       Date:  2011-03-22       Impact factor: 5.157

5.  Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage.

Authors:  G Z Rassidakis; A H Sarris; M Herling; R J Ford; F Cabanillas; T J McDonnell; L J Medeiros
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

Review 6.  Anaplastic large cell lymphoma, ALK-negative.

Authors:  Andrés J M Ferreri; Silvia Govi; Stefano A Pileri; Kerry J Savage
Journal:  Crit Rev Oncol Hematol       Date:  2012-07-11       Impact factor: 6.312

7.  Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death.

Authors:  Alberto Zamo; Roberto Chiarle; Roberto Piva; Jennifer Howes; Yan Fan; Marco Chilosi; David E Levy; Giorgio Inghirami
Journal:  Oncogene       Date:  2002-02-07       Impact factor: 9.867

8.  Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma.

Authors:  Ellen J Schlette; L Jeffrey Medeiros; Andre Goy; Raymond Lai; George Z Rassidakis
Journal:  J Clin Oncol       Date:  2004-05-01       Impact factor: 44.544

9.  Bortezomib-induced apoptosis in mature T-cell lymphoma cells partially depends on upregulation of Noxa and functional repression of Mcl-1.

Authors:  Masaki Ri; Shinsuke Iida; Takashi Ishida; Asahi Ito; Hiroki Yano; Atsushi Inagaki; Jianmin Ding; Shigeru Kusumoto; Hirokazu Komatsu; Atae Utsunomiya; Ryuzo Ueda
Journal:  Cancer Sci       Date:  2009-02       Impact factor: 6.716

10.  p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas.

Authors:  Jian-Zhong Qin; Lawrence Stennett; Patricia Bacon; Barbara Bodner; Mary J C Hendrix; Richard E B Seftor; Elisabeth A Seftor; Naira V Margaryan; Pamela M Pollock; Amy Curtis; Jeffrey M Trent; Frank Bennett; Lucio Miele; Brian J Nickoloff
Journal:  Mol Cancer Ther       Date:  2004-08       Impact factor: 6.261
View more
  3 in total

1.  Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas.

Authors:  Raphael Koch; Amanda L Christie; Jennifer L Crombie; Adam C Palmer; Deborah Plana; Kay Shigemori; Sara N Morrow; Alexandria Van Scoyk; Wenchao Wu; Elizabeth A Brem; J Paul Secrist; Lisa Drew; Alwin G Schuller; Justin Cidado; Anthony Letai; David M Weinstock
Journal:  Blood       Date:  2018-11-29       Impact factor: 22.113

2.  Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines.

Authors:  Rufino Mondejar; Cristina Pérez; Arantza Onaindia; Nerea Martinez; Julia González-Rincón; Helena Pisonero; Jose Pedro Vaqué; Laura Cereceda; Miguel Santibañez; Margarita Sánchez-Beato; Miguel Angel Piris
Journal:  PLoS One       Date:  2017-05-15       Impact factor: 3.240

3.  The Long Non-Coding RNA MIR503HG Enhances Proliferation of Human ALK-Negative Anaplastic Large-Cell Lymphoma.

Authors:  Po-Shuan Huang; I-Hsiao Chung; Yang-Hsiang Lin; Tzu-Kang Lin; Wei-Jan Chen; Kwang-Huei Lin
Journal:  Int J Mol Sci       Date:  2018-05-14       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.